Despite accumulating evidence of inter and intraindividual variability in response to theta burst stimulation, it is widely believed that in therapeutic applications, repeated sessions can have a "build-up" effect that increases the response over and above that seen in a single session. However, strong evidence for this is lacking. Therefore, we examined whether daily administration of intermittent theta burst stimulation (iTBS) over the primary motor cortex induces cumulative changes in transcranial magnetic stimulation measures of cortical excitability, above the changes induced by sham stimulation. Over five consecutive days, 20 healthy participants received either active iTBS or sham stimulation. Each day, baseline measures of cortical excitability were assessed before and up to 30 min after the intervention. There was no significant difference in the rate of response between iTBS and sham stimulation on any of the 5 days. There was no iTBS specific cumulative increase of corticospinal excitability. The likelihood that an individual would remain a responder from day-to-day was low in both groups, implying high within-subject variability of both active and sham iTBS after-effects. In contrast, we found a high within-subject repeatability of resting and active motor threshold, and baseline motor-evoked potential amplitude.
| INTRODUCTION
Theta Burst Stimulation (TBS) protocols consist of highfrequency gamma bursts, repeated at a theta frequency that can induce after-effects on the excitability of the stimulated area (Capocchi, Zampolini, & Larson, 1992) . In humans, when TBS is applied intermittently (iTBS) over the primary motor cortex (M1), it may facilitate corticospinal excitability (long-term potentiation-like effect), conversely, when applied continuously (cTBS), it may decrease corticospinal excitability (long-term depression-like effects) (Huang, Edwards, Rounis, Bhatia, & Rothwell, 2005) . TBS protocols have gained attention during the last decade, because they are quick to apply, require subthreshold stimulation intensities, and are therefore more practical and potentially safer to administer than classical high-and low-frequency repetitive transcranial magnetic stimulation (rTMS) protocols (Daskalakis, 2014; Huang et al., 2005; Suppa et al., 2016) . Recent evidence suggests that TBS protocols have a variable effect on cortical excitability among different subjects, with a high proportion of subjects either not responding or responding in the opposite direction from what is expected (Hamada, Murase, Hasan, Balaratnam, & Rothwell, 2013; Hordacre et al., 2017; LopezAlonso, Cheeran, Rio-Rodriguez, & Fernandez-Del-Olmo, 2014; Vallence et al., 2015; Vernet et al., 2014) . This calls into question both the efficacy of TBS as an experimental method for probing brain plasticity and its usefulness as a therapeutic tool. The within-subject variability of the rTMS aftereffect has been less investigated, however, it is considered to be lower than the between-subject variability (Sommer, Wu, Tergau, & Paulus, 2002) . Numerous studies have tried to define potential sources of variability, including gender differences (Vernet et al., 2014) , genetic factors (Hoppenrath & Funke, 2013) , early life events (Pitcher et al., 2012) , target muscle preactivation (Gentner, Wankerl, Reinsberger, Zeller, & Classen, 2008; Iezzi et al., 2008) and time of the day when experiments are performed (Sale, Ridding, & Nordstrom, 2008) . Other suggested factors are: history of synaptic plasticity (Murakami, Muller-Dahlhaus, Lu, & Ziemann, 2012) , between-subject differences in intracortical neurons that are activated by stimualtion (Hamada et al., 2013) or differences in functional connectivity (Nettekoven et al., 2014 (Nettekoven et al., , 2015 . However, none of these factors seem sufficient to explain all the variance observed. Little is known about the contribution of the placebo effect to the overall response to rTMS protocols (Duecker & Sack, 2015) and, in particular, about its contribution to the variability of the rTMS response.
The issue of the efficacy of rTMS as a plasticity-inducing tool is of clinical importance. It is widely believed that a clinically significant response to therapeutic applications of rTMS occurs if sessions of rTMS are repeated over a period of several days (Lefaucheur et al., 2014) . This "build-up" effect presumably results from cumulative brain changes that potentiate the effect of single stimulations. The evidence supporting cumulative effects has been scarce, both in animal studies (Valero-Cabre, Pascual-Leone, & Rushmore, 2008) and in patient populations (Avenanti, Coccia, Ladavas, Provinciali, & Ceravolo, 2012; Khedr, Rothwell, Shawky, Ahmed, & Hamdy, 2006; Kim et al., 2015; Kimberley, Borich, Arora, & Siebner, 2013; Munneke et al., 2013) , and the mechanism through which this might be occurring remains uninvestigated.
In this study, we tested whether daily administration of iTBS over the M1 produces cumulative changes in transcranial magnetic stimulation (TMS) measures of cortical excitability, over and above the changes induced by sham stimulation. We hypothesized that cumulative changes would cause progressive increase of iTBS after-effects in individual volunteers and/or increase the number of subjects who respond to iTBS.
Consecutive days of stimulation were chosen to imitate the design usually applied in clinical studies (Lefaucheur et al., 2014) . In order to mimic the anticipatory expectations of patients undergoing such protocols in the clinical setting, we did not inform participants that there was a sham treatment group. In fact, irrespective of the protocol received, participants were told that gradual change in excitability over the week is to be expected. Our hypothesis was that if iTBS has a specific cumulative effect, then the response over 5 days to active stimulation should be greater than the response to sham stimulation. Conversely, if there is no specific effect, then, any changes over time (either increases or decreases) should be equally evident in both groups. In order to account for the possibility that effects of repeated iTBS stimulation occur by modifying levels of intracortical excitability (Siebner, 2010; Ziemann & Siebner, 2008) , measures of intracortical inhibition and facilitation were also recorded.
| MATERIALS AND METHODS

| Participants
Twenty healthy volunteers (7 males, 13 females), aged between 18 and 31 years (M = 23.3, SD = 3.5) participated in the study. One participant was left handed, as determined by the Edinburgh Handedness Inventory (Oldfield, 1971) . All procedures were performed in accordance with the Declaration of Helsinki and were approved by the National Medical Ethics Committee of Slovenia. All subjects gave written informed consent.
| Electromyography recording
Participants were seated in a comfortable chair not facing the computer screen. Electromyographic activity (EMG) was
recorded from the dominant first dorsal interosseous (FDI) muscle using disposable bipolar silver-silver chloride electrodes. EMG was band-pass filtered (20-2,000 Hz) and amplified (gain 1,000) using a D360 amplifier (Digitimer Ltd, Welwyn Garden City, UK). The amplified EMG was sampled at 5 kHz using a Micro1401-3 data acquisition unit (Cambridge Electronic Design Limited, Cambridge, UK) coupled with Signal 5.1 software (Cambridge Electronic Design Limited).
| Transcranial magnetic stimulation
Transcranial magnetic stimulation was applied over the FDI muscle representation in the M1, contralateral to the target muscle. The FDI "hotspot" was defined as the position at which single pulse TMS produced the largest motor-evoked potentials (MEPs) in the contralateral FDI muscle. Single and paired pulse TMS was administered using Magstim 200 stimulators with a 70 mm figure-of-eight coil, whereas TBS was administered using a Magstim Rapid2 with an air-cooled 70 mm figure-of-eight coil (Magstim Company, Whitland, UK). The coil was held tangentially to the scalp, with the handle pointing posteriorly at a 45-degree angle with the midline, which is optimal for evoking electrical currents in a posterior-anterior direction within the motor cortex.
| Corticospinal excitability
Active motor threshold (AMT) was defined as the minimum stimulus intensity evoking a discernible MEP (>200 μV amplitude) in at least half of six trials during mild contraction (approximately 10%-20% of maximum voluntary contraction) of the FDI muscle. Resting motor threshold (RMT) was defined as the minimum stimulus intensity evoking a discernible MEP (>50 μV amplitude) in at least half of 6 trials. AMT was measured using the Magstim Rapid2 stimulator, whereas RMT was measured using the Magstim 200 stimulator.
Baseline MEP amplitude was assessed by recording 20 MEPs from the FDI muscle at an intensity of 120% of RMT (Rossini et al., 2015) . After either active or sham iTBS, seven blocks of 20 MEPs at 120% of baseline RMT were recorded, first immediately after iTBS and then every 5 min up to 30 min after iTBS.
| Intracortical excitability
Short-latency intracortical inhibition (SICI) and intracortical facilitation (ICF) were recorded at rest using a standard paired-pulse paradigm (Kujirai et al., 1993) . The intensity of the conditioning stimulus was set at 80% of AMT, whereas the intensity of the test stimulus was set at 120% of RMT. SICI and ICF were assessed by delivering 10-paired pulses at 2, 3, 4, and 15 ms interstimulus intervals (ISIs) and 10 test single pulses, in a randomized fashion.
| Active and sham iTBS techniques
Active iTBS involved 2 s trains of TBS (3 pulses at 50 Hz repeated at 200 ms intervals) that occurred every 10 s for a total of 190 s (600 pulses). Stimulation intensity of the theta burst interventions was set to 80% of AMT in each session (Huang et al., 2005) . Sham iTBS was delivered with the same parameters as in the active group but with the coil tilted so that only the side of the right edge of the coil remains in contact with the scalp at the FDI hot spot (Lisanby, Gutman, Luber, Schroeder, & Sackeim, 2001 ). This way, the subject can still hear the clicking sound the coil emits and feel the pressure of the coil, but the magnetic field strength is weakened enough not to induce any current in brain tissue. During both types of interventions, an experimenter ensured that participants kept their arms relaxed and looked passively forwards.
| Experimental design
Participants were told that cortical excitability would be measured first and, then, a plasticity protocol would be applied to try and temporarily increase cortical excitability. They were told that, in order to study possible cumulative effects, the same procedure would be repeated for five consecutive days. Participants were not aware that half of them would receive sham stimulation. All participants were naïve to TMS as they had not participated in any TMS study previously. Participants were randomly assigned to either active or sham iTBS. For each individual participant, five consecutive experimental sessions were conducted at the same time of day, in order to control for any diurnal effects on corticospinal plasticity. All participants were stimulated between 9 a.m. and 2 p.m. and both groups where matched for the number of subjects that did the experiment before or after 12 p.m. In each session, we measured RMT, AMT, and MEPs. Then, active or sham iTBS was delivered and MEPs re-measured up to 30 min, every 5 min. SICI and ICF were recorded before active and sham iTBS, only on days 1 and 5 ( Figure 1 ).
| Definition of responders
We defined "responders" and "nonresponders", in both active and sham groups, according to the change in average MEP amplitude after stimulation. To exclude random fluctuations around the baseline level, we used the cut-off values of 10% and 20%. Subjects were classified as "responders" if, after stimulation, they showed increase in average MEP amplitude >10% (or >20%) compared to baseline average MEP amplitude (Hinder et al., 2014; Nettekoven et al., 2015) , otherwise they were considered "nonresponders". We also defined as "opposite responders" those subjects who showed a decrease >10% (or >20%) from baseline (Table 1) .
| Data analysis
Cortical excitability and paired pulse protocols data were preprocessed using our own custom made C++ analysis software. Further data manipulations were performed using custom made Matlab (MathWorks, Inc. Chicago, IL, USA) scripts. Statistical analysis and resulting figures and tables were done in R using RStudio (RStudio, Inc. Boston, MA, USA).
We first ensured that there was no muscle activity prior to each TMS pulse. Trials in which the root mean square amplitude of the 100 ms prior to the TMS pulse was larger than 50 μV, were excluded from further analysis. Peak to peak amplitudes were measured for each trial, averaged for each block and paired pulse ISI (for SICI and ICF) and expressed as a ratio of the baseline or test stimuli mean, respectively. Ratio normalization was carried out according to the formula: Hinder et al., 2014; Sinclair & Hammond, 2009) . ShapiroWilk test (W = 0.834, p < 0.001), assessment of kurtosis (10.9) and skewness (SE = 2.37) indicated that normalized average MEP amplitudes were not normally distributed and were skewed. Therefore, natural logarithm transformation was applied to all normalized average data (Sinclair & Hammond, 2009 ). Means and standard deviations reported in this paper are back-transformed.
| Statistical analysis
A mixed design ANOVA was used to investigate the differences between the active iTBS and sham groups for each of the measures of interest (RMT, AMT, post-iTBS MEPs and SICI/ICF across the 5 days). When a significant main effect was found, pairwise analysis with Bonferroni correction was used. Contingency tables and Fisher's exact test (FET) were used to determine the independence of the response rate from day 1 and day 5, as well as the independence of the response rate between groups (iTBS vs. sham). The analysis was performed separately for each cutoff (10% and 20%). The reliability of RMT, AMT, and baseline MEPs, across the 5 days, was assessed with Intraclass Correlation Coefficient estimates based on mean rating (k = 5), absolute-agreement, two-way random-effects model, ICC (2, k). We did not use ICC to assess the repeatability of active and sham iTBS induced changes in corticospinal excitability (after-effect) or for the repeatability of SICI and ICF, because these measures are expressed as a ratio of the baseline and test stimulus, respectively. Normalization of the data reduces the total variance of the data, and thus reduces the ICC estimates of variability, rendering ICC a nonsuitable measure for repeatability of normalized data (Koo & Li, 2016) . In order to assess within-subject variability in the response to active and sham iTBS, we used Fleiss' kappa (Fleiss, 1971) , for each group and cutoff separately. This test assesses the reliability of the binary stimulation effect (responder vs. nonresponder) in the same participant across the 5 days.
3 | RESULTS
| Effects of active and sham iTBS on corticospinal excitability
Mixed design ANOVA on RMT with one within-subject factor (day, 5 levels) and one between-subject factor (group, 2 levels), revealed a significant main effect of day (F 4,72 = 5.30, p = 0.001, ƞ 2 = 0.013), but not of group. Post hoc analysis revealed that RMT was significantly larger in day 1 (M = 44.5, SD = 7.37, p = 0.014) than in day 2 (M = 42.9, SD = 7.39). There was no significant interaction between group and day. Similarly, mixed design ANOVA on AMT revealed a significant main effect of day (F 4,72 = 2.84, p = 0.030, ƞ 2 = 0.015), but not of group. There was no significant interaction between the two factors. Post hoc analysis with Bonferroni correction did not reveal any significant differences between days due to the relatively small effect size.
To assess possible differences in baseline MEP amplitude between groups, we used mixed design ANOVA with a within-subject factor (day, 5 levels) and a between subject factor (group, 2 levels), on log transformed average baseline MEP amplitude. This analysis revealed a significant main effect of day, (F 4,72 = 2.30, p = 0.043, ƞ 2 = 0.6), but not of group, or their interaction. However, post hoc analysis did not reveal any significant differences between the days due to the relatively small effect. Moreover, the mean amplitude of the baseline was 0.891 mV (SD = 1.67) and 0.890 mV (SD = 1.87) in the active and sham iTBS groups, respectively. These results indicate that baseline MEP amplitude did not differ between groups on any of the days of stimulation. To assess the differences between the effects of the active and sham iTBS groups on MEP amplitude, we performed mixed design ANOVA on log normalized average post-iTBS MEP amplitude with two within-subject factors (day, 5 levels, and block, 7 levels) and a between-subject factor (group, 2 levels). The analysis revealed a significant main effect of day (F 4,72 = 3.64, p = 0.009, ƞ 2 = 0.079). Post hoc analysis with Bonferroni correction revealed this was due to log transformed normalized average MEP amplitude on day 5 being significantly larger (M = 0.351, SD = 0.56) than on days 1-4 (M = 0.129, SD = 0.503, p = 0.004; M = 0.004, SD = 0.635, p < 0.001; M = 0.135, SD = 0.569, p = 0.003; M = −0.071, SD = 0.563, p < 0.001). Additionally, log transformed normalized average MEP amplitude on day 4 was significantly smaller than in day 1 (p = 0.004) and day 3 (p = 0.001). The main effect of group and block, as well as their interaction, was not significant, indicating that the effect of stimulation on corticospinal excitability was the same in both sham and active groups (Figure 2 ). Given the variability in mean effect across days, we conclude that there was no evidence for a general upward trend in the data over the consecutive days.
| SICI and ICF
Mixed design ANOVA on SICI with two within-subject factors (day, 2 levels; ISI, 3 levels) and a between-subject factor (group, 2 levels) revealed a statistically significant main effect of ISI (F 3,54 = 10.86, p = 0.001). This was due to less SICI at 4 ms ISI (M = −0.189, SD = 0.718) than at 2 ms ISI (M = −0.390, SD = 0.732, p = 0.002) and 3 ms ISI (M = −0.389, SD = 0.940, p = 0.001). There was no significant main effect of day and group, as well as no significant interactions (Figure 3 ). Mixed design ANOVA on ICF, with a within-subject factor (day, 2 levels) and a between-subject factor (group, 2 levels), revealed no significant main effect or interaction. These results indicate that the two groups did not differ in baseline SICI and ICF on the first day of stimulation, and that a 4-day course of either active or sham iTBS did not affect intracortical inhibition or facilitation. Table 2 .
| Reliability of the baseline TMS measures across days
| Variability of the response to active and sham iTBS
To assess differences in the overall number of responders between groups, we first expressed the raw average post-iTBS MEP amplitude in all blocks as a percentage of baseline, then we averaged together all post-iTBS time blocks for each day in every participant and coded them as either responders or nonresponders for each cutoff separately. Contingency table (active vs. sham) and FET revealed no significant difference in the rate of response between the active and sham iTBS groups, neither for 10% (p = 0.106, FET) nor 20% (p = 0.106, FET) cutoff (Table 1) .
The relationship between the rate of response on days 1 and 5 was assessed for each group and cutoff separately. FET revealed no significant change in response rate from day 1 to day 5 in either group, for any of the cutoff values (iTBS, 10% cutoff: p = 1, 20% cutoff: p = 1; sham, 10% cutoff: p = 0.58, 20% cutoff: p = 0.35).
The likelihood that an individual would remain a responder from day-to-day was low in both active and sham iTBS groups, for either 10% (κ = 0.159, p = 0.113 and κ = −0.07, p = 0.487, for active and sham groups, respectively), or for 20% (κ = 0.02, p = 0.845 and κ = 0.039, p = 0.701, for active and sham groups, respectively) cutoff values. 
| DISCUSSION
We report four main findings of the study. (a) The effect of active iTBS was not different from the effect of sham stimulation on any of the 5 days; (b) Repeated sessions of iTBS did not produce a cumulative effect (over and above placebo) on corticospinal excitability, neither did they change the number of "responders"; (b) There were some day-to-day changes in the response to both active and sham iTBS, however, these were the same in both groups; (d) AMT, RMT, and baseline MEPs were highly repeatable measures across the different sessions.
| The effect of active and sham iTBS on corticospinal excitability
There are two novel findings in the present data. First, even over a 5-day "treatment" protocol, active iTBS was not superior to sham stimulation at inducing long-lasting facilitation of corticospinal excitability. Second, there was no evidence, in either group, of a steady increase in the response to iTBS. These conclusions were the same whether we analyzed the whole group data or separated the participants into "responders" and "nonresponders".
As noted in the Introduction, any specific cumulative effect of iTBS should have been evident as a gradual separation between the iTBS and sham groups, in their response over the 5 days. The fact that this was not observed, suggests that either there is no specific effect of iTBS or that it was too small for us to observe with our experimental design. Despite the lack of a group difference, there was an overall effect of time in that the response to both active and sham iTBS changed over the 5 days, being smaller on day 4 and larger on day 5, compared to day 1. It is possible that some of these nonspecific effects of time were the result of expectations. For example, the awareness that the day 5 was the last day of stimulation could have resulted in an increase in MEP amplitude, considering that subjects were told in advance that the procedure will be repeated for five consecutive days in order to study possible cumulative effects. However, this is only speculation, as we did not obtain measures of expectation, to test its relationships with TMS effects.
| Between and within-subject variability in response to iTBS
Although initial studies reported a clear facilitatory aftereffect of single session iTBS on corticospinal excitability (Huang, Chen, Rothwell, & Wen, 2007; Huang et al., 2005) , recent studies using larger samples of healthy subjects have shown a lack of group effect to both iTBS and cTBS, as well as to other experimental plasticity protocols (Hamada et al., 2013; Lopez-Alonso et al., 2014) . This is apparently due to large between-subject variability in response to noninvasive brain stimulation (NIBS) protocols. The source of variability in response to NIBS remains largely unresolved, but differences between subjects in intrinsic mechanisms of synaptic plasticity (Ridding & Ziemann, 2010 ) might be involved. Alternatively, it has been suggested that variability may be the result of preferential stimulation of certain populations of cortical neurons or differences in prestimulation level of excitability of the neurons (Day et al., 1989; Rothwell, 1997) .
One way to quantify the interindividual variability of iTBS effects is to measure the proportion of "responders" and nonresponders" to the protocol. In the study by Hamada et al. (2013) , the responses of 52 individuals to both iTBS and cTBS were highly variable, with overall no significant changes in corticospinal excitability after TBS at the group level. When the response to iTBS was defined operationally, according to whether the grand average effect was above or below 1, authors found almost equal numbers (52% vs. 48%) of participants who responded in the expected (facilitatory) as in the opposite (inhibitory) direction. In the present paper, we used a more rigorous definition of "responders" which was introduced by Nettekoven Values correspond to the mean RMT and AMT stimulation intensities, expressed as a percentage of maximum output from the stimulator. Values in parenthesis correspond to the standard deviation. The overall higher intensities of AMT are due to the fact that it was measured using Magstim Rapid2, which produces biphasic pulse waveforms and delivers less power overall than the single pulse stimulator, hence the need for relatively higher intensities.
T A B L E 2 Average RMT and AMT for each group and day et al. (2015) . "Responders" are defined as participants who have a post-iTBS increase in MEP amplitude 10% or 20% above baseline. When we applied these criteria to both groups, we found no significant difference in the number of responders to active and sham iTBS from day 1 to day 5 (Table 1) . At the lower cutoff of 10%, on the first day of stimulation, there were 60% of "responders "in the active group and 70% of responders in the sham group. Increasing the cutoff value to 20% revealed similar findings, with 40% of responders in the active and 50% in the sham group. A similar situation occurred on each of the 5 days. Even though the number of participants in our groups was not high, the observed ratio of responders is very similar to the findings of Hamada et al. (2013) , including the proportion of individuals responding in the direction opposite to what is expected (Table 1 ). The novel finding of our study is that there was the same frequency of responders in the active and sham iTBS groups.
| Day-to-day (within-subject) variability in the response to active and sham iTBS
For the purposes of the present experiment, the most important measure is the day-to-day intraindividual variation in response to iTBS. Few previous studies have examined whether the effect of TBS on the motor cortex is repeatable in the same subjects on different occasions (Fried, Jannati, Davila-Perez, & Pascual-Leone, 2017; Hinder et al., 2014; Vallence et al., 2015) . Even though these studies found that the effect of TBS may be similar on different days at a group level, within individual repeatability was low in the latest studies (Fried et al., 2017; Vallence et al., 2015) , as estimated by low ICC value. However, ICC can underestimate the repeatability of data which is expressed as a ratio, that is, normalization of the data reduces the total variance of the data, which in turn, reduces the ICC estimates of variability (Koo & Li, 2016) .
For this reason, we tested the repeatability of active and sham iTBS-induced changes on corticospinal excitability using Fleiss' kappa instead. This test allowed us to assess whether the same subject behaved in a similar way over the 5 days. As indicated by a low Fleiss' kappa and illustrated in Figure 4 , we found low reproducibility. In other words, a participant could be a "responder" 1 day and a "nonresponder" another day.
Reconciling our data with findings from previous studies, we conclude that, at an individual level, the response to TBS (and probably to NIBS in general) is not a predetermined characteristic of the motor cortex (Day et al., 1989; Rothwell, 1997) .
| The effect of active and sham iTBS on intracortical excitability
We found no effect on ICF or inhibition, after 4 days of either active iTBS or sham stimulation, as measured by changes in SICI and ICF between the 1st and 5th day. A recent metaanalysis (Chung, Hill, Rogasch, Hoy, & Fitzgerald, 2016) revealed no changes in SICI or ICF after a single session of iTBS. Our results further suggest that there is no cumulative effect of repeated sessions of iTBS on intracortical inhibition and facilitation.
| Reliability of other measures of interest
In our study, RMT and AMT were the most reliable measures of cortical excitability as defined by ICC. This strengthens the findings of previous studies (Liu & Au-Yeung, 2014; Ngomo, Leonard, Moffet, & Mercier, 2012) , which measured the same parameters on two occasions only. We also found that average baseline MEPs, measured at 120% of RMT, are relatively stable in our participants across days.
| STUDY LIMITATIONS
The main limitation of our study is the relatively small number of participants in each group, However, it is noteworthy that the measurements were performed five times in each participant, totaling to 100 separate experiments/observations. Moreover, since the two groups did not differ in any of the measures of interest, the analysis of reliability could be performed on pooled data, therefore increasing the statistical power of the analysis.
| POSSIBLE RELEVANCE OF OUR FINDINGS
The fact that there were no differences between active and sham iTBS in our study, coupled with the fact that there was a similar proportion of responders in both groups, suggests that placebo effect might play an important role in the response to rTMS. The placebo effect is closely related to expectations. Laboratory and clinical study have shown that, when people ingest a pharmacologically inert substance, but believe that it is an active substance, they experience measurable physiologic effects expected from that active substance (Benedetti, Carlino, & Pollo, 2010) . Therefore, a placebo response to rTMS is not surprising, particularly when considering the robustness and impressiveness of the TMS and EMG equipment. It is worth noticing that a recent meta-analysis of studies in depression showed that although the response rate (defined ≥50% reduction in posttreatment depression scores) was significantly higher in iTBS-treated patients, remission rates were not significantly different between patients treated with active and sham stimulation (Berlim, McGirr, Rodrigues Dos Santos, Tremblay, & Martins, 2017) .
| CONCLUSIONS
We performed the first sham-controlled study investigating the effects of iTBS on corticospinal excitability across five consecutive days. The results suggest that iTBS is not better suited than sham to produce long-lasting facilitation of corticospinal excitability. We also investigated possible cumulative effects of repeated (5 days) stimulation and, while there were small changes between days, all effects were present in equal magnitude in both groups. RMT, AMT, and baseline MEPs were highly repeatable across five consecutive days. On the other hand, iTBS after-effects had low repeatability, suggesting high within-subject variability. The results of this study are relevant for both research and clinical applications of TBS plasticity protocols and further stress the need to conduct large-scale sham-controlled studies.
